Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by aldo451on Apr 15, 2019 11:38pm

164 Views

Post# 29631272

RE:RE:Aldo - RE:RE:Roger 1234 if 75 million dollars is exercise

HI Roger,

Makes sense. Here’s hoping for some positive announcements between now and the "rights offering"

Thank you for taking the time, I really do appreciate your balanced view, it is quite refreshing to say the least.

All that’s best.
Aldo

roger1234 wrote: I don't think the rights themselves will be tradable at $0.01521, and nothing garantees that you will be able to trade the new shares at that same price on the market.

Consolidation, a trading halt, other material annoucements, etc. could occur and (presumably) increase the share price. After all, why would anyone who just paid that price immediately return on on the market to sell them -- other than at a higher price to make a significant profit.

Always keep in mind what the big players (institutional holders) are doing and/or anticipating, and make your move accordingly.

GLTA